140 related articles for article (PubMed ID: 6181869)
1. Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia.
Pretlow TG; Whitehurst GB; Pretlow TP; Hunt RS; Jacobs JM; McKenzie DR; McDaniel HG; Hall LM; Bradley EL
Cancer Res; 1982 Nov; 42(11):4842-8. PubMed ID: 6181869
[TBL] [Abstract][Full Text] [Related]
2. Enzyme activities in prostatic carcinoma related to Gleason grades.
Pretlow TG; Harris BE; Bradley EL; Bueschen AJ; Lloyd KL; Pretlow TP
Cancer Res; 1985 Jan; 45(1):442-6. PubMed ID: 3155494
[TBL] [Abstract][Full Text] [Related]
3. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
[TBL] [Abstract][Full Text] [Related]
4. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma.
Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA
Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600
[TBL] [Abstract][Full Text] [Related]
5. 5'-nucleotidase activity in prostatic carcinoma and benign prostatic hyperplasia.
Rackley RR; Lewis TJ; Preston EM; Delmoro CM; Bradley EL; Resnick MI; Pretlow TP; Pretlow TG
Cancer Res; 1989 Jul; 49(13):3702-7. PubMed ID: 2471588
[TBL] [Abstract][Full Text] [Related]
6. The significance of creatine kinase (CKBB) in metastatic cancer of the prostate.
Forman DT
Ann Clin Lab Sci; 1979; 9(4):333-7. PubMed ID: 485095
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
Durocher Y; Chapdelaine A; Chevalier S
Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
[TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
9. Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate.
Koren R; Ben Meir D; Langzam L; Dekel Y; Konichezky M; Baniel J; Livne PM; Gal R; Sampson SR
Oncol Rep; 2004 Feb; 11(2):321-6. PubMed ID: 14719062
[TBL] [Abstract][Full Text] [Related]
10. Creatine phosphokinase isoenzymes in human prostatic tissues: a comparison between benign hyperplasia and adenocarcinoma.
Truong T; Carmel M; Elhilali M; Cloutier D; Lehoux JG
Prostate; 1985; 7(2):143-9. PubMed ID: 2413430
[TBL] [Abstract][Full Text] [Related]
11. Assessment of serum radioimmune and enzymatic prostatic acid phosphatase and radioimmune creatine kinase BB for monitoring response to therapy in metastatic prostatic carcinoma.
Zweig MH; Ihde DC
Cancer Res; 1985 Aug; 45(8):3945-50. PubMed ID: 3893691
[TBL] [Abstract][Full Text] [Related]
12. [Determination of CK-BB (E.C.2.7.3.2) in advanced stages of carcinoma of the prostate].
Jansen S; Mayor J; Arenas J; Fraile B; Santos I; Díaz-González R; Leiva O; Borobia V; Martínez A
Actas Urol Esp; 1986; 10(1):25-8. PubMed ID: 2425557
[No Abstract] [Full Text] [Related]
13. Immunoexpressions of p21, Rb, mcl-1 and bad gene products in normal, hyperplastic and carcinomatous human prostates.
Royuela M; Arenas MI; Bethencourt FR; Sánchez-Chapado M; Fraile B; Paniagua R
Eur Cytokine Netw; 2001; 12(4):654-63. PubMed ID: 11781193
[TBL] [Abstract][Full Text] [Related]
14. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.
Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C
Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081
[TBL] [Abstract][Full Text] [Related]
15. The expression of neuropeptides in hyperplastic and malignant prostate tissue and its possible clinical implications.
Yu DS; Hsieh DS; Chen HI; Chang SY
J Urol; 2001 Sep; 166(3):871-5. PubMed ID: 11490236
[TBL] [Abstract][Full Text] [Related]
16. Assessment of radioimmunoassay of serum creatine kinase BB (CK-BB) as a tumor marker: studies in patients with various cancers and a comparison of CK-BB concentrations to prostate acid phosphatase concentrations.
Zweig MH; Van Steirteghem AC
J Natl Cancer Inst; 1981 May; 66(5):659-62. PubMed ID: 6939925
[TBL] [Abstract][Full Text] [Related]
17. Enzyme markers in human prostatic carcinoma.
Chu TM; Wang MC; Kuciel R; Valenzuela L; Murphy GP
Cancer Treat Rep; 1977; 61(2):193-200. PubMed ID: 68822
[TBL] [Abstract][Full Text] [Related]
18. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia].
Zang T; Sun F; Li Y
Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclooxygenase-2 in prostate adenocarcinoma and benign prostatic hyperplasia.
Lee LM; Pan CC; Cheng CJ; Chi CW; Liu TY
Anticancer Res; 2001; 21(2B):1291-4. PubMed ID: 11396201
[TBL] [Abstract][Full Text] [Related]
20. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
